Acorda Therapeutics, Inc.

NASDAQ:ACOR

0.66 (USD) • At close April 11, 2024
Bedrijfsnaam Acorda Therapeutics, Inc.
Symbool ACOR
Munteenheid USD
Prijs 0.661
Beurswaarde 821,028
Dividendpercentage 0%
52-weken bereik 0.612 - 24.2
Industrie Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Dr. Ron Cohen M.D.
Website https://www.acorda.com

An error occurred while fetching data.

Over Acorda Therapeutics, Inc.

Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in patients with multiple sclerosis (MS); and Inbrija for the treatment of OFF periods in Parkinson's disease in Europe. It also markets

Vergelijkbare Aandelen

Evofem Biosciences, Inc. logo

Evofem Biosciences, Inc.

EVFM

0.07 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)